CNPAX
Price
$73.46
Change
+$0.79 (+1.09%)
Updated
Oct 20 closing price
Net Assets
162.86B
MGFRX
Price
$10.05
Change
+$0.11 (+1.11%)
Updated
Oct 20 closing price
Net Assets
153.94M
Interact to see
Advertisement

CNPAX vs MGFRX

Header iconCNPAX vs MGFRX Comparison
Open Charts CNPAX vs MGFRXBanner chart's image
American Funds New Perspective 529A
Price$73.46
Change+$0.79 (+1.09%)
VolumeN/A
Net Assets162.86B
MassMutual Global R4
Price$10.05
Change+$0.11 (+1.11%)
VolumeN/A
Net Assets153.94M
CNPAX vs MGFRX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MGFRX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and MGFRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. MGFRX (154M). CNPAX pays higher dividends than MGFRX: CNPAX (0.46) vs MGFRX (0.00). CNPAX was incepted earlier than MGFRX: CNPAX (24 years) vs MGFRX (12 years). MGFRX (1.38) is less costly to investors than CNPAX (0.77). CNPAX is a more actively managed with annual turnover of: 24.00 vs. MGFRX (6.00). MGFRX has a lower initial minimum investment than CNPAX: MGFRX (0) vs CNPAX (250). CNPAX annual gain was more profitable for investors over the last year : 12.70 vs. MGFRX (-3.40). CNPAX return over 5 years is better than : 35.90 vs. MGFRX (-34.26).
CNPAXMGFRXCNPAX / MGFRX
Total Expense Ratio0.771.3856%
Annual Report Gross Expense Ratio0.771.3856%
Fund Existence24 years12 years-
Gain YTD19.07312.316155%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets163B154M105,844%
Annual Yield % from dividends0.460.00-
Returns for 1 year12.70-3.40-373%
Returns for 3 years62.46-5.69-1,097%
Returns for 5 years35.90-34.26-105%
Returns for 10 years106.83-29.43-363%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDX26.830.28
+1.05%
Celldex Therapeutics
DMAAU10.50N/A
N/A
Drugs Made In America Acquisition Corp
MOV17.87-0.03
-0.17%
Movado Group
BYFC6.93-0.08
-1.17%
Broadway Financial Corp
OVV35.97-0.47
-1.29%
Ovintiv